First Indication. The choice of the First Indication will be stated in the Development Plan and will be the focus of initial clinical development activities thereunder to support regulatory approval of Compound Product in Japan.
Appears in 3 contracts
Sources: Development Agreement, Development Agreement (Threshold Pharmaceuticals Inc), Development Agreement (Threshold Pharmaceuticals Inc)